DELRAY BEACH, Fla., Aug. 15, 2025 /PRNewswire/ -- The global Epigenetics Market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025...
Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update.
"With cutting-edge advances in next-generation sequencing and growing interest in personalized medicine, whole genome sequencing is set to transform disease diagnosis and treatment, driving...
Strategic partnership brings first-of-its-kind artificial intelligence capabilities to North American inspection services
WICHITA, Kan., Aug. 11, 2025 /PRNewswire/ -- PROtect, LLC, a leader in safety,...
Renowned Longevity Researcher Reveals Highlights of New Study to NBJ Conference Guests
FERNANDINA BEACH, Fla., Aug. 11, 2025 /PRNewswire/ -- Dr. Brian Kennedy, one of...
Record-breaking performance at U.S. uranium mine to drive lower-cost U3O8 production; advancement of world class rare earth element and heavy mineral sands projects, including...
Record-breaking performance at U.S. uranium mine to drive lower-cost U3O8 production; advancement of world class rare earth element and heavy mineral sands projects, including...
The Biomarkers Market is anticipated to expand at a rapid pace due to the increasing demand for personalized medicine, rising prevalence of chronic and...
Record second quarter Adjusted EBITDA1 of $508 million
Demonstrates strength and run rate potential of Parkland's diversified business
Advancing the Sunoco Transaction2
CALGARY, AB, Aug. 5, 2025...
Record second quarter Adjusted EBITDA1 of $508 million
Demonstrates strength and run rate potential of Parkland's diversified business
Advancing the Sunoco Transaction2
CALGARY, AB, Aug. 5, 2025...
Record second quarter Adjusted EBITDA1 of $508 million
Demonstrates strength and run rate potential of Parkland's diversified business
Advancing the Sunoco Transaction2
CALGARY, AB, Aug. 5, 2025...
TORONTO, Aug. 1, 2025 /CNW/ - On July 31, 2025, MTL Cannabis Corp. (CSE: MTLC) ("MTL Cannabis") voluntarily prepaid to Archerwill Investments Inc. ("Archerwill")...